Agriculture
Global Live Brucellosis Vaccine Market Research Report 2026
- Feb 03, 26
- ID: 688412
- Pages: 153
- Figures: 149
- Views: 4
This report delivers a comprehensive overview of the global Live Brucellosis Vaccine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Live Brucellosis Vaccine. The Live Brucellosis Vaccine market size, estimates, and forecasts are provided in terms of shipments (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Live Brucellosis Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Live Brucellosis Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
CZ Vaccines
MSD
Ceva
Colorado Serum
Tecnovax
Syva
Shchelkovo Biocombinat
Jinyu Baoling
Biovet
CAVAC
VETAL
Indian Immunologicals
Dollvet
Hester Biosciences
Qilu Animal Health
Auleon Biologicals
Segment by Type
Strain RB-51
Strain S19
Strain S2
Strain A19
Strain Rev. I
by Application
Cattle
Sheep
Pig
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Egypt
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Live Brucellosis Vaccine manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Live Brucellosis Vaccine production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Live Brucellosis Vaccine consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
The report segments the global Live Brucellosis Vaccine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Live Brucellosis Vaccine manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
CZ Vaccines
MSD
Ceva
Colorado Serum
Tecnovax
Syva
Shchelkovo Biocombinat
Jinyu Baoling
Biovet
CAVAC
VETAL
Indian Immunologicals
Dollvet
Hester Biosciences
Qilu Animal Health
Auleon Biologicals
Segment by Type
Strain RB-51
Strain S19
Strain S2
Strain A19
Strain Rev. I
by Application
Cattle
Sheep
Pig
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Egypt
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Live Brucellosis Vaccine manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Live Brucellosis Vaccine production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Live Brucellosis Vaccine consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
1 Live Brucellosis Vaccine Market Overview
1.1 Product Definition
1.2 Live Brucellosis Vaccine by Type
1.2.1 Global Live Brucellosis Vaccine Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Strain RB-51
1.2.3 Strain S19
1.2.4 Strain S2
1.2.5 Strain A19
1.2.6 Strain Rev. I
1.3 Live Brucellosis Vaccine by Application
1.3.1 Global Live Brucellosis Vaccine Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Cattle
1.3.3 Sheep
1.3.4 Pig
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Live Brucellosis Vaccine Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Live Brucellosis Vaccine Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Live Brucellosis Vaccine Production Estimates and Forecasts (2021–2032)
1.4.4 Global Live Brucellosis Vaccine Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Live Brucellosis Vaccine Production Market Share by Manufacturers (2021–2026)
2.2 Global Live Brucellosis Vaccine Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Live Brucellosis Vaccine, Industry Ranking, 2024 vs 2025
2.4 Global Live Brucellosis Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Live Brucellosis Vaccine Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Live Brucellosis Vaccine, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Live Brucellosis Vaccine, Product Offerings and Applications
2.8 Global Key Manufacturers of Live Brucellosis Vaccine, Date of Entry into the Industry
2.9 Live Brucellosis Vaccine Market Competitive Situation and Trends
2.9.1 Live Brucellosis Vaccine Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Live Brucellosis Vaccine Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Live Brucellosis Vaccine Production by Region
3.1 Global Live Brucellosis Vaccine Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Live Brucellosis Vaccine Production Value by Region (2021–2032)
3.2.1 Global Live Brucellosis Vaccine Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Live Brucellosis Vaccine by Region (2027–2032)
3.3 Global Live Brucellosis Vaccine Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Live Brucellosis Vaccine Production Volume by Region (2021–2032)
3.4.1 Global Live Brucellosis Vaccine Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Live Brucellosis Vaccine by Region (2027–2032)
3.5 Global Live Brucellosis Vaccine Market Price Analysis by Region (2021–2026)
3.6 Global Live Brucellosis Vaccine Production, Value, and Year-over-Year Growth
3.6.1 North America Live Brucellosis Vaccine Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Live Brucellosis Vaccine Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Live Brucellosis Vaccine Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Live Brucellosis Vaccine Production Value Estimates and Forecasts (2021–2032)
4 Live Brucellosis Vaccine Consumption by Region
4.1 Global Live Brucellosis Vaccine Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Live Brucellosis Vaccine Consumption by Region (2021–2032)
4.2.1 Global Live Brucellosis Vaccine Consumption by Region (2021–2026)
4.2.2 Global Live Brucellosis Vaccine Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Live Brucellosis Vaccine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Live Brucellosis Vaccine Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Live Brucellosis Vaccine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Live Brucellosis Vaccine Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Live Brucellosis Vaccine Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Live Brucellosis Vaccine Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Live Brucellosis Vaccine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Live Brucellosis Vaccine Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Live Brucellosis Vaccine Production by Type (2021–2032)
5.1.1 Global Live Brucellosis Vaccine Production by Type (2021–2026)
5.1.2 Global Live Brucellosis Vaccine Production by Type (2027–2032)
5.1.3 Global Live Brucellosis Vaccine Production Market Share by Type (2021–2032)
5.2 Global Live Brucellosis Vaccine Production Value by Type (2021–2032)
5.2.1 Global Live Brucellosis Vaccine Production Value by Type (2021–2026)
5.2.2 Global Live Brucellosis Vaccine Production Value by Type (2027–2032)
5.2.3 Global Live Brucellosis Vaccine Production Value Market Share by Type (2021–2032)
5.3 Global Live Brucellosis Vaccine Price by Type (2021–2032)
6 Segment by Application
6.1 Global Live Brucellosis Vaccine Production by Application (2021–2032)
6.1.1 Global Live Brucellosis Vaccine Production by Application (2021–2026)
6.1.2 Global Live Brucellosis Vaccine Production by Application (2027–2032)
6.1.3 Global Live Brucellosis Vaccine Production Market Share by Application (2021–2032)
6.2 Global Live Brucellosis Vaccine Production Value by Application (2021–2032)
6.2.1 Global Live Brucellosis Vaccine Production Value by Application (2021–2026)
6.2.2 Global Live Brucellosis Vaccine Production Value by Application (2027–2032)
6.2.3 Global Live Brucellosis Vaccine Production Value Market Share by Application (2021–2032)
6.3 Global Live Brucellosis Vaccine Price by Application (2021–2032)
7 Key Companies Profiled
7.1 CZ Vaccines
7.1.1 CZ Vaccines Live Brucellosis Vaccine Company Information
7.1.2 CZ Vaccines Live Brucellosis Vaccine Product Portfolio
7.1.3 CZ Vaccines Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 CZ Vaccines Main Business and Markets Served
7.1.5 CZ Vaccines Recent Developments/Updates
7.2 MSD
7.2.1 MSD Live Brucellosis Vaccine Company Information
7.2.2 MSD Live Brucellosis Vaccine Product Portfolio
7.2.3 MSD Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 MSD Main Business and Markets Served
7.2.5 MSD Recent Developments/Updates
7.3 Ceva
7.3.1 Ceva Live Brucellosis Vaccine Company Information
7.3.2 Ceva Live Brucellosis Vaccine Product Portfolio
7.3.3 Ceva Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Ceva Main Business and Markets Served
7.3.5 Ceva Recent Developments/Updates
7.4 Colorado Serum
7.4.1 Colorado Serum Live Brucellosis Vaccine Company Information
7.4.2 Colorado Serum Live Brucellosis Vaccine Product Portfolio
7.4.3 Colorado Serum Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Colorado Serum Main Business and Markets Served
7.4.5 Colorado Serum Recent Developments/Updates
7.5 Tecnovax
7.5.1 Tecnovax Live Brucellosis Vaccine Company Information
7.5.2 Tecnovax Live Brucellosis Vaccine Product Portfolio
7.5.3 Tecnovax Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Tecnovax Main Business and Markets Served
7.5.5 Tecnovax Recent Developments/Updates
7.6 Syva
7.6.1 Syva Live Brucellosis Vaccine Company Information
7.6.2 Syva Live Brucellosis Vaccine Product Portfolio
7.6.3 Syva Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Syva Main Business and Markets Served
7.6.5 Syva Recent Developments/Updates
7.7 Shchelkovo Biocombinat
7.7.1 Shchelkovo Biocombinat Live Brucellosis Vaccine Company Information
7.7.2 Shchelkovo Biocombinat Live Brucellosis Vaccine Product Portfolio
7.7.3 Shchelkovo Biocombinat Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Shchelkovo Biocombinat Main Business and Markets Served
7.7.5 Shchelkovo Biocombinat Recent Developments/Updates
7.8 Jinyu Baoling
7.8.1 Jinyu Baoling Live Brucellosis Vaccine Company Information
7.8.2 Jinyu Baoling Live Brucellosis Vaccine Product Portfolio
7.8.3 Jinyu Baoling Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Jinyu Baoling Main Business and Markets Served
7.8.5 Jinyu Baoling Recent Developments/Updates
7.9 Biovet
7.9.1 Biovet Live Brucellosis Vaccine Company Information
7.9.2 Biovet Live Brucellosis Vaccine Product Portfolio
7.9.3 Biovet Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Biovet Main Business and Markets Served
7.9.5 Biovet Recent Developments/Updates
7.10 CAVAC
7.10.1 CAVAC Live Brucellosis Vaccine Company Information
7.10.2 CAVAC Live Brucellosis Vaccine Product Portfolio
7.10.3 CAVAC Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 CAVAC Main Business and Markets Served
7.10.5 CAVAC Recent Developments/Updates
7.11 VETAL
7.11.1 VETAL Live Brucellosis Vaccine Company Information
7.11.2 VETAL Live Brucellosis Vaccine Product Portfolio
7.11.3 VETAL Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 VETAL Main Business and Markets Served
7.11.5 VETAL Recent Developments/Updates
7.12 Indian Immunologicals
7.12.1 Indian Immunologicals Live Brucellosis Vaccine Company Information
7.12.2 Indian Immunologicals Live Brucellosis Vaccine Product Portfolio
7.12.3 Indian Immunologicals Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.12.4 Indian Immunologicals Main Business and Markets Served
7.12.5 Indian Immunologicals Recent Developments/Updates
7.13 Dollvet
7.13.1 Dollvet Live Brucellosis Vaccine Company Information
7.13.2 Dollvet Live Brucellosis Vaccine Product Portfolio
7.13.3 Dollvet Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.13.4 Dollvet Main Business and Markets Served
7.13.5 Dollvet Recent Developments/Updates
7.14 Hester Biosciences
7.14.1 Hester Biosciences Live Brucellosis Vaccine Company Information
7.14.2 Hester Biosciences Live Brucellosis Vaccine Product Portfolio
7.14.3 Hester Biosciences Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.14.4 Hester Biosciences Main Business and Markets Served
7.14.5 Hester Biosciences Recent Developments/Updates
7.15 Qilu Animal Health
7.15.1 Qilu Animal Health Live Brucellosis Vaccine Company Information
7.15.2 Qilu Animal Health Live Brucellosis Vaccine Product Portfolio
7.15.3 Qilu Animal Health Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.15.4 Qilu Animal Health Main Business and Markets Served
7.15.5 Qilu Animal Health Recent Developments/Updates
7.16 Auleon Biologicals
7.16.1 Auleon Biologicals Live Brucellosis Vaccine Company Information
7.16.2 Auleon Biologicals Live Brucellosis Vaccine Product Portfolio
7.16.3 Auleon Biologicals Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.16.4 Auleon Biologicals Main Business and Markets Served
7.16.5 Auleon Biologicals Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Live Brucellosis Vaccine Industry Chain Analysis
8.2 Live Brucellosis Vaccine Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Live Brucellosis Vaccine Production Modes and Processes
8.4 Live Brucellosis Vaccine Sales and Marketing
8.4.1 Live Brucellosis Vaccine Sales Channels
8.4.2 Live Brucellosis Vaccine Distributors
8.5 Live Brucellosis Vaccine Customer Analysis
9 Live Brucellosis Vaccine Market Dynamics
9.1 Live Brucellosis Vaccine Industry Trends
9.2 Live Brucellosis Vaccine Market Drivers
9.3 Live Brucellosis Vaccine Market Challenges
9.4 Live Brucellosis Vaccine Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
1.1 Product Definition
1.2 Live Brucellosis Vaccine by Type
1.2.1 Global Live Brucellosis Vaccine Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Strain RB-51
1.2.3 Strain S19
1.2.4 Strain S2
1.2.5 Strain A19
1.2.6 Strain Rev. I
1.3 Live Brucellosis Vaccine by Application
1.3.1 Global Live Brucellosis Vaccine Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Cattle
1.3.3 Sheep
1.3.4 Pig
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Live Brucellosis Vaccine Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Live Brucellosis Vaccine Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Live Brucellosis Vaccine Production Estimates and Forecasts (2021–2032)
1.4.4 Global Live Brucellosis Vaccine Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Live Brucellosis Vaccine Production Market Share by Manufacturers (2021–2026)
2.2 Global Live Brucellosis Vaccine Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Live Brucellosis Vaccine, Industry Ranking, 2024 vs 2025
2.4 Global Live Brucellosis Vaccine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Live Brucellosis Vaccine Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Live Brucellosis Vaccine, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Live Brucellosis Vaccine, Product Offerings and Applications
2.8 Global Key Manufacturers of Live Brucellosis Vaccine, Date of Entry into the Industry
2.9 Live Brucellosis Vaccine Market Competitive Situation and Trends
2.9.1 Live Brucellosis Vaccine Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Live Brucellosis Vaccine Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Live Brucellosis Vaccine Production by Region
3.1 Global Live Brucellosis Vaccine Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Live Brucellosis Vaccine Production Value by Region (2021–2032)
3.2.1 Global Live Brucellosis Vaccine Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Live Brucellosis Vaccine by Region (2027–2032)
3.3 Global Live Brucellosis Vaccine Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Live Brucellosis Vaccine Production Volume by Region (2021–2032)
3.4.1 Global Live Brucellosis Vaccine Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Live Brucellosis Vaccine by Region (2027–2032)
3.5 Global Live Brucellosis Vaccine Market Price Analysis by Region (2021–2026)
3.6 Global Live Brucellosis Vaccine Production, Value, and Year-over-Year Growth
3.6.1 North America Live Brucellosis Vaccine Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Live Brucellosis Vaccine Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Live Brucellosis Vaccine Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Live Brucellosis Vaccine Production Value Estimates and Forecasts (2021–2032)
4 Live Brucellosis Vaccine Consumption by Region
4.1 Global Live Brucellosis Vaccine Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Live Brucellosis Vaccine Consumption by Region (2021–2032)
4.2.1 Global Live Brucellosis Vaccine Consumption by Region (2021–2026)
4.2.2 Global Live Brucellosis Vaccine Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Live Brucellosis Vaccine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Live Brucellosis Vaccine Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Live Brucellosis Vaccine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Live Brucellosis Vaccine Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Live Brucellosis Vaccine Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Live Brucellosis Vaccine Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Live Brucellosis Vaccine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Live Brucellosis Vaccine Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Live Brucellosis Vaccine Production by Type (2021–2032)
5.1.1 Global Live Brucellosis Vaccine Production by Type (2021–2026)
5.1.2 Global Live Brucellosis Vaccine Production by Type (2027–2032)
5.1.3 Global Live Brucellosis Vaccine Production Market Share by Type (2021–2032)
5.2 Global Live Brucellosis Vaccine Production Value by Type (2021–2032)
5.2.1 Global Live Brucellosis Vaccine Production Value by Type (2021–2026)
5.2.2 Global Live Brucellosis Vaccine Production Value by Type (2027–2032)
5.2.3 Global Live Brucellosis Vaccine Production Value Market Share by Type (2021–2032)
5.3 Global Live Brucellosis Vaccine Price by Type (2021–2032)
6 Segment by Application
6.1 Global Live Brucellosis Vaccine Production by Application (2021–2032)
6.1.1 Global Live Brucellosis Vaccine Production by Application (2021–2026)
6.1.2 Global Live Brucellosis Vaccine Production by Application (2027–2032)
6.1.3 Global Live Brucellosis Vaccine Production Market Share by Application (2021–2032)
6.2 Global Live Brucellosis Vaccine Production Value by Application (2021–2032)
6.2.1 Global Live Brucellosis Vaccine Production Value by Application (2021–2026)
6.2.2 Global Live Brucellosis Vaccine Production Value by Application (2027–2032)
6.2.3 Global Live Brucellosis Vaccine Production Value Market Share by Application (2021–2032)
6.3 Global Live Brucellosis Vaccine Price by Application (2021–2032)
7 Key Companies Profiled
7.1 CZ Vaccines
7.1.1 CZ Vaccines Live Brucellosis Vaccine Company Information
7.1.2 CZ Vaccines Live Brucellosis Vaccine Product Portfolio
7.1.3 CZ Vaccines Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 CZ Vaccines Main Business and Markets Served
7.1.5 CZ Vaccines Recent Developments/Updates
7.2 MSD
7.2.1 MSD Live Brucellosis Vaccine Company Information
7.2.2 MSD Live Brucellosis Vaccine Product Portfolio
7.2.3 MSD Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 MSD Main Business and Markets Served
7.2.5 MSD Recent Developments/Updates
7.3 Ceva
7.3.1 Ceva Live Brucellosis Vaccine Company Information
7.3.2 Ceva Live Brucellosis Vaccine Product Portfolio
7.3.3 Ceva Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Ceva Main Business and Markets Served
7.3.5 Ceva Recent Developments/Updates
7.4 Colorado Serum
7.4.1 Colorado Serum Live Brucellosis Vaccine Company Information
7.4.2 Colorado Serum Live Brucellosis Vaccine Product Portfolio
7.4.3 Colorado Serum Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Colorado Serum Main Business and Markets Served
7.4.5 Colorado Serum Recent Developments/Updates
7.5 Tecnovax
7.5.1 Tecnovax Live Brucellosis Vaccine Company Information
7.5.2 Tecnovax Live Brucellosis Vaccine Product Portfolio
7.5.3 Tecnovax Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Tecnovax Main Business and Markets Served
7.5.5 Tecnovax Recent Developments/Updates
7.6 Syva
7.6.1 Syva Live Brucellosis Vaccine Company Information
7.6.2 Syva Live Brucellosis Vaccine Product Portfolio
7.6.3 Syva Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Syva Main Business and Markets Served
7.6.5 Syva Recent Developments/Updates
7.7 Shchelkovo Biocombinat
7.7.1 Shchelkovo Biocombinat Live Brucellosis Vaccine Company Information
7.7.2 Shchelkovo Biocombinat Live Brucellosis Vaccine Product Portfolio
7.7.3 Shchelkovo Biocombinat Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Shchelkovo Biocombinat Main Business and Markets Served
7.7.5 Shchelkovo Biocombinat Recent Developments/Updates
7.8 Jinyu Baoling
7.8.1 Jinyu Baoling Live Brucellosis Vaccine Company Information
7.8.2 Jinyu Baoling Live Brucellosis Vaccine Product Portfolio
7.8.3 Jinyu Baoling Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Jinyu Baoling Main Business and Markets Served
7.8.5 Jinyu Baoling Recent Developments/Updates
7.9 Biovet
7.9.1 Biovet Live Brucellosis Vaccine Company Information
7.9.2 Biovet Live Brucellosis Vaccine Product Portfolio
7.9.3 Biovet Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Biovet Main Business and Markets Served
7.9.5 Biovet Recent Developments/Updates
7.10 CAVAC
7.10.1 CAVAC Live Brucellosis Vaccine Company Information
7.10.2 CAVAC Live Brucellosis Vaccine Product Portfolio
7.10.3 CAVAC Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 CAVAC Main Business and Markets Served
7.10.5 CAVAC Recent Developments/Updates
7.11 VETAL
7.11.1 VETAL Live Brucellosis Vaccine Company Information
7.11.2 VETAL Live Brucellosis Vaccine Product Portfolio
7.11.3 VETAL Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 VETAL Main Business and Markets Served
7.11.5 VETAL Recent Developments/Updates
7.12 Indian Immunologicals
7.12.1 Indian Immunologicals Live Brucellosis Vaccine Company Information
7.12.2 Indian Immunologicals Live Brucellosis Vaccine Product Portfolio
7.12.3 Indian Immunologicals Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.12.4 Indian Immunologicals Main Business and Markets Served
7.12.5 Indian Immunologicals Recent Developments/Updates
7.13 Dollvet
7.13.1 Dollvet Live Brucellosis Vaccine Company Information
7.13.2 Dollvet Live Brucellosis Vaccine Product Portfolio
7.13.3 Dollvet Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.13.4 Dollvet Main Business and Markets Served
7.13.5 Dollvet Recent Developments/Updates
7.14 Hester Biosciences
7.14.1 Hester Biosciences Live Brucellosis Vaccine Company Information
7.14.2 Hester Biosciences Live Brucellosis Vaccine Product Portfolio
7.14.3 Hester Biosciences Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.14.4 Hester Biosciences Main Business and Markets Served
7.14.5 Hester Biosciences Recent Developments/Updates
7.15 Qilu Animal Health
7.15.1 Qilu Animal Health Live Brucellosis Vaccine Company Information
7.15.2 Qilu Animal Health Live Brucellosis Vaccine Product Portfolio
7.15.3 Qilu Animal Health Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.15.4 Qilu Animal Health Main Business and Markets Served
7.15.5 Qilu Animal Health Recent Developments/Updates
7.16 Auleon Biologicals
7.16.1 Auleon Biologicals Live Brucellosis Vaccine Company Information
7.16.2 Auleon Biologicals Live Brucellosis Vaccine Product Portfolio
7.16.3 Auleon Biologicals Live Brucellosis Vaccine Production, Value, Price, and Gross Margin (2021–2026)
7.16.4 Auleon Biologicals Main Business and Markets Served
7.16.5 Auleon Biologicals Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Live Brucellosis Vaccine Industry Chain Analysis
8.2 Live Brucellosis Vaccine Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Live Brucellosis Vaccine Production Modes and Processes
8.4 Live Brucellosis Vaccine Sales and Marketing
8.4.1 Live Brucellosis Vaccine Sales Channels
8.4.2 Live Brucellosis Vaccine Distributors
8.5 Live Brucellosis Vaccine Customer Analysis
9 Live Brucellosis Vaccine Market Dynamics
9.1 Live Brucellosis Vaccine Industry Trends
9.2 Live Brucellosis Vaccine Market Drivers
9.3 Live Brucellosis Vaccine Market Challenges
9.4 Live Brucellosis Vaccine Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
Table 1. Global Live Brucellosis Vaccine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Live Brucellosis Vaccine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Live Brucellosis Vaccine Production Capacity (K Units) by Manufacturers in 2025
Table 4. Global Live Brucellosis Vaccine Production by Manufacturers (K Units), 2021–2026
Table 5. Global Live Brucellosis Vaccine Production Market Share by Manufacturers (2021–2026)
Table 6. Global Live Brucellosis Vaccine Production Value by Manufacturers (US$ Million), 2021–2026
Table 7. Global Live Brucellosis Vaccine Production Value Share by Manufacturers (2021–2026)
Table 8. Global Key Players of Live Brucellosis Vaccine, Industry Ranking, 2024 vs 2025
Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Live Brucellosis Vaccine Production Value, 2025
Table 10. Global Market Live Brucellosis Vaccine Average Price by Manufacturers (US$/Unit), 2021–2026
Table 11. Global Key Manufacturers of Live Brucellosis Vaccine, Manufacturing Footprints and Headquarters
Table 12. Global Key Manufacturers of Live Brucellosis Vaccine, Product Offerings and Applications
Table 13. Global Key Manufacturers of Live Brucellosis Vaccine, Date of Entry into the Industry
Table 14. Global Live Brucellosis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Live Brucellosis Vaccine Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Live Brucellosis Vaccine Production Value (US$ Million) by Region (2021–2026)
Table 18. Global Live Brucellosis Vaccine Production Value Market Share by Region (2021–2026)
Table 19. Global Live Brucellosis Vaccine Production Value (US$ Million) Forecast by Region (2027–2032)
Table 20. Global Live Brucellosis Vaccine Production Value Market Share Forecast by Region (2027–2032)
Table 21. Global Live Brucellosis Vaccine Production Comparison by Region: 2021 vs 2025 vs 2032 (K Units)
Table 22. Global Live Brucellosis Vaccine Production (K Units) by Region (2021–2026)
Table 23. Global Live Brucellosis Vaccine Production Market Share by Region (2021–2026)
Table 24. Global Live Brucellosis Vaccine Production (K Units) Forecast by Region (2027–2032)
Table 25. Global Live Brucellosis Vaccine Production Market Share Forecast by Region (2027–2032)
Table 26. Global Live Brucellosis Vaccine Market Average Price (US$/Unit) by Region (2021–2026)
Table 27. Global Live Brucellosis Vaccine Market Average Price (US$/Unit) by Region (2027–2032)
Table 28. Global Live Brucellosis Vaccine Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (K Units)
Table 29. Global Live Brucellosis Vaccine Consumption by Region (K Units), 2021–2026
Table 30. Global Live Brucellosis Vaccine Consumption Market Share by Region (2021–2026)
Table 31. Global Live Brucellosis Vaccine Forecasted Consumption by Region (K Units), 2027–2032
Table 32. Global Live Brucellosis Vaccine Forecasted Consumption Market Share by Region (2027–2032)
Table 33. North America Live Brucellosis Vaccine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (K Units)
Table 34. North America Live Brucellosis Vaccine Consumption by Country (K Units), 2021–2026
Table 35. North America Live Brucellosis Vaccine Consumption by Country (K Units), 2027–2032
Table 36. Europe Live Brucellosis Vaccine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (K Units)
Table 37. Europe Live Brucellosis Vaccine Consumption by Country (K Units), 2021–2026
Table 38. Europe Live Brucellosis Vaccine Consumption by Country (K Units), 2027–2032
Table 39. Asia Pacific Live Brucellosis Vaccine Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (K Units)
Table 40. Asia Pacific Live Brucellosis Vaccine Consumption by Region (K Units), 2021–2026
Table 41. Asia Pacific Live Brucellosis Vaccine Consumption by Region (K Units), 2027–2032
Table 42. Latin America, Middle East & Africa Live Brucellosis Vaccine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (K Units)
Table 43. Latin America, Middle East & Africa Live Brucellosis Vaccine Consumption by Country (K Units), 2021–2026
Table 44. Latin America, Middle East & Africa Live Brucellosis Vaccine Consumption by Country (K Units), 2027–2032
Table 45. Global Live Brucellosis Vaccine Production (K Units) by Type (2021–2026)
Table 46. Global Live Brucellosis Vaccine Production (K Units) by Type (2027–2032)
Table 47. Global Live Brucellosis Vaccine Production Market Share by Type (2021–2026)
Table 48. Global Live Brucellosis Vaccine Production Market Share by Type (2027–2032)
Table 49. Global Live Brucellosis Vaccine Production Value (US$ Million) by Type (2021–2026)
Table 50. Global Live Brucellosis Vaccine Production Value (US$ Million) by Type (2027–2032)
Table 51. Global Live Brucellosis Vaccine Production Value Market Share by Type (2021–2026)
Table 52. Global Live Brucellosis Vaccine Production Value Market Share by Type (2027–2032)
Table 53. Global Live Brucellosis Vaccine Price (US$/Unit) by Type (2021–2026)
Table 54. Global Live Brucellosis Vaccine Price (US$/Unit) by Type (2027–2032)
Table 55. Global Live Brucellosis Vaccine Production (K Units) by Application (2021–2026)
Table 56. Global Live Brucellosis Vaccine Production (K Units) by Application (2027–2032)
Table 57. Global Live Brucellosis Vaccine Production Market Share by Application (2021–2026)
Table 58. Global Live Brucellosis Vaccine Production Market Share by Application (2027–2032)
Table 59. Global Live Brucellosis Vaccine Production Value (US$ Million) by Application (2021–2026)
Table 60. Global Live Brucellosis Vaccine Production Value (US$ Million) by Application (2027–2032)
Table 61. Global Live Brucellosis Vaccine Production Value Market Share by Application (2021–2026)
Table 62. Global Live Brucellosis Vaccine Production Value Market Share by Application (2027–2032)
Table 63. Global Live Brucellosis Vaccine Price (US$/Unit) by Application (2021–2026)
Table 64. Global Live Brucellosis Vaccine Price (US$/Unit) by Application (2027–2032)
Table 65. CZ Vaccines Live Brucellosis Vaccine Company Information
Table 66. CZ Vaccines Live Brucellosis Vaccine Specification and Application
Table 67. CZ Vaccines Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 68. CZ Vaccines Main Business and Markets Served
Table 69. CZ Vaccines Recent Developments/Updates
Table 70. MSD Live Brucellosis Vaccine Company Information
Table 71. MSD Live Brucellosis Vaccine Specification and Application
Table 72. MSD Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 73. MSD Main Business and Markets Served
Table 74. MSD Recent Developments/Updates
Table 75. Ceva Live Brucellosis Vaccine Company Information
Table 76. Ceva Live Brucellosis Vaccine Specification and Application
Table 77. Ceva Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 78. Ceva Main Business and Markets Served
Table 79. Ceva Recent Developments/Updates
Table 80. Colorado Serum Live Brucellosis Vaccine Company Information
Table 81. Colorado Serum Live Brucellosis Vaccine Specification and Application
Table 82. Colorado Serum Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 83. Colorado Serum Main Business and Markets Served
Table 84. Colorado Serum Recent Developments/Updates
Table 85. Tecnovax Live Brucellosis Vaccine Company Information
Table 86. Tecnovax Live Brucellosis Vaccine Specification and Application
Table 87. Tecnovax Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 88. Tecnovax Main Business and Markets Served
Table 89. Tecnovax Recent Developments/Updates
Table 90. Syva Live Brucellosis Vaccine Company Information
Table 91. Syva Live Brucellosis Vaccine Specification and Application
Table 92. Syva Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 93. Syva Main Business and Markets Served
Table 94. Syva Recent Developments/Updates
Table 95. Shchelkovo Biocombinat Live Brucellosis Vaccine Company Information
Table 96. Shchelkovo Biocombinat Live Brucellosis Vaccine Specification and Application
Table 97. Shchelkovo Biocombinat Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 98. Shchelkovo Biocombinat Main Business and Markets Served
Table 99. Shchelkovo Biocombinat Recent Developments/Updates
Table 100. Jinyu Baoling Live Brucellosis Vaccine Company Information
Table 101. Jinyu Baoling Live Brucellosis Vaccine Specification and Application
Table 102. Jinyu Baoling Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 103. Jinyu Baoling Main Business and Markets Served
Table 104. Jinyu Baoling Recent Developments/Updates
Table 105. Biovet Live Brucellosis Vaccine Company Information
Table 106. Biovet Live Brucellosis Vaccine Specification and Application
Table 107. Biovet Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 108. Biovet Main Business and Markets Served
Table 109. Biovet Recent Developments/Updates
Table 110. CAVAC Live Brucellosis Vaccine Company Information
Table 111. CAVAC Live Brucellosis Vaccine Specification and Application
Table 112. CAVAC Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 113. CAVAC Main Business and Markets Served
Table 114. CAVAC Recent Developments/Updates
Table 115. VETAL Live Brucellosis Vaccine Company Information
Table 116. VETAL Live Brucellosis Vaccine Specification and Application
Table 117. VETAL Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 118. VETAL Main Business and Markets Served
Table 119. VETAL Recent Developments/Updates
Table 120. Indian Immunologicals Live Brucellosis Vaccine Company Information
Table 121. Indian Immunologicals Live Brucellosis Vaccine Specification and Application
Table 122. Indian Immunologicals Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 123. Indian Immunologicals Main Business and Markets Served
Table 124. Indian Immunologicals Recent Developments/Updates
Table 125. Dollvet Live Brucellosis Vaccine Company Information
Table 126. Dollvet Live Brucellosis Vaccine Specification and Application
Table 127. Dollvet Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 128. Dollvet Main Business and Markets Served
Table 129. Dollvet Recent Developments/Updates
Table 130. Hester Biosciences Live Brucellosis Vaccine Company Information
Table 131. Hester Biosciences Live Brucellosis Vaccine Specification and Application
Table 132. Hester Biosciences Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 133. Hester Biosciences Main Business and Markets Served
Table 134. Hester Biosciences Recent Developments/Updates
Table 135. Qilu Animal Health Live Brucellosis Vaccine Company Information
Table 136. Qilu Animal Health Live Brucellosis Vaccine Specification and Application
Table 137. Qilu Animal Health Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 138. Qilu Animal Health Main Business and Markets Served
Table 139. Qilu Animal Health Recent Developments/Updates
Table 140. Auleon Biologicals Live Brucellosis Vaccine Company Information
Table 141. Auleon Biologicals Live Brucellosis Vaccine Specification and Application
Table 142. Auleon Biologicals Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 143. Auleon Biologicals Main Business and Markets Served
Table 144. Auleon Biologicals Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Live Brucellosis Vaccine Distributors List
Table 148. Live Brucellosis Vaccine Customers List
Table 149. Live Brucellosis Vaccine Market Trends
Table 150. Live Brucellosis Vaccine Market Drivers
Table 151. Live Brucellosis Vaccine Market Challenges
Table 152. Live Brucellosis Vaccine Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Live Brucellosis Vaccine
Figure 2. Global Live Brucellosis Vaccine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Live Brucellosis Vaccine Market Share by Type: 2025 vs 2032
Figure 4. Strain RB-51 Product Picture
Figure 5. Strain S19 Product Picture
Figure 6. Strain S2 Product Picture
Figure 7. Strain A19 Product Picture
Figure 8. Strain Rev. I Product Picture
Figure 9. Global Live Brucellosis Vaccine Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Live Brucellosis Vaccine Market Share by Application: 2025 vs 2032
Figure 11. Cattle
Figure 12. Sheep
Figure 13. Pig
Figure 14. Others
Figure 15. Global Live Brucellosis Vaccine Production Value (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Live Brucellosis Vaccine Production Value (US$ Million), 2021–2032
Figure 17. Global Live Brucellosis Vaccine Production Capacity (K Units), 2021–2032
Figure 18. Global Live Brucellosis Vaccine Production (K Units), 2021–2032
Figure 19. Global Live Brucellosis Vaccine Average Price (US$/Unit), 2021–2032
Figure 20. Live Brucellosis Vaccine Report Years Considered
Figure 21. Live Brucellosis Vaccine Production Share by Manufacturers in 2025
Figure 22. Global Live Brucellosis Vaccine Production Value Share by Manufacturers (2025)
Figure 23. Live Brucellosis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 24. Top 5 and Top 10 Global Players: Market Share by Live Brucellosis Vaccine Revenue in 2025
Figure 25. Global Live Brucellosis Vaccine Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 26. Global Live Brucellosis Vaccine Production Value Market Share by Region: 2021 vs 2025 vs 2032
Figure 27. Global Live Brucellosis Vaccine Production Comparison by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 28. Global Live Brucellosis Vaccine Production Market Share by Region: 2021 vs 2025 vs 2032
Figure 29. North America Live Brucellosis Vaccine Production Value (US$ Million) Growth Rate (2021–2032)
Figure 30. Europe Live Brucellosis Vaccine Production Value (US$ Million) Growth Rate (2021–2032)
Figure 31. China Live Brucellosis Vaccine Production Value (US$ Million) Growth Rate (2021–2032)
Figure 32. Japan Live Brucellosis Vaccine Production Value (US$ Million) Growth Rate (2021–2032)
Figure 33. Global Live Brucellosis Vaccine Consumption by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 34. Global Live Brucellosis Vaccine Consumption Market Share by Region: 2021 vs 2025 vs 2032
Figure 35. North America Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 36. North America Live Brucellosis Vaccine Consumption Market Share by Country (2021–2032)
Figure 37. U.S. Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 38. Canada Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 39. Europe Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 40. Europe Live Brucellosis Vaccine Consumption Market Share by Country (2021–2032)
Figure 41. Germany Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 42. France Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 43. U.K. Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 44. Italy Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 45. Russia Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 46. Asia Pacific Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 47. Asia Pacific Live Brucellosis Vaccine Consumption Market Share by Region (2021–2032)
Figure 48. China Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 49. Japan Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 50. South Korea Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 51. China Taiwan Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 52. Southeast Asia Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 53. India Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 54. Latin America, Middle East & Africa Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 55. Latin America, Middle East & Africa Live Brucellosis Vaccine Consumption Market Share by Country (2021–2032)
Figure 56. Mexico Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 57. Brazil Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 58. Turkey Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 59. GCC Countries Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 60. Global Production Market Share of Live Brucellosis Vaccine by Type (2021–2032)
Figure 61. Global Production Value Market Share of Live Brucellosis Vaccine by Type (2021–2032)
Figure 62. Global Live Brucellosis Vaccine Price (US$/Unit) by Type (2021–2032)
Figure 63. Global Production Market Share of Live Brucellosis Vaccine by Application (2021–2032)
Figure 64. Global Production Value Market Share of Live Brucellosis Vaccine by Application (2021–2032)
Figure 65. Global Live Brucellosis Vaccine Price (US$/Unit) by Application (2021–2032)
Figure 66. Live Brucellosis Vaccine Value Chain
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Table 1. Global Live Brucellosis Vaccine Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Live Brucellosis Vaccine Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Live Brucellosis Vaccine Production Capacity (K Units) by Manufacturers in 2025
Table 4. Global Live Brucellosis Vaccine Production by Manufacturers (K Units), 2021–2026
Table 5. Global Live Brucellosis Vaccine Production Market Share by Manufacturers (2021–2026)
Table 6. Global Live Brucellosis Vaccine Production Value by Manufacturers (US$ Million), 2021–2026
Table 7. Global Live Brucellosis Vaccine Production Value Share by Manufacturers (2021–2026)
Table 8. Global Key Players of Live Brucellosis Vaccine, Industry Ranking, 2024 vs 2025
Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Live Brucellosis Vaccine Production Value, 2025
Table 10. Global Market Live Brucellosis Vaccine Average Price by Manufacturers (US$/Unit), 2021–2026
Table 11. Global Key Manufacturers of Live Brucellosis Vaccine, Manufacturing Footprints and Headquarters
Table 12. Global Key Manufacturers of Live Brucellosis Vaccine, Product Offerings and Applications
Table 13. Global Key Manufacturers of Live Brucellosis Vaccine, Date of Entry into the Industry
Table 14. Global Live Brucellosis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Live Brucellosis Vaccine Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Live Brucellosis Vaccine Production Value (US$ Million) by Region (2021–2026)
Table 18. Global Live Brucellosis Vaccine Production Value Market Share by Region (2021–2026)
Table 19. Global Live Brucellosis Vaccine Production Value (US$ Million) Forecast by Region (2027–2032)
Table 20. Global Live Brucellosis Vaccine Production Value Market Share Forecast by Region (2027–2032)
Table 21. Global Live Brucellosis Vaccine Production Comparison by Region: 2021 vs 2025 vs 2032 (K Units)
Table 22. Global Live Brucellosis Vaccine Production (K Units) by Region (2021–2026)
Table 23. Global Live Brucellosis Vaccine Production Market Share by Region (2021–2026)
Table 24. Global Live Brucellosis Vaccine Production (K Units) Forecast by Region (2027–2032)
Table 25. Global Live Brucellosis Vaccine Production Market Share Forecast by Region (2027–2032)
Table 26. Global Live Brucellosis Vaccine Market Average Price (US$/Unit) by Region (2021–2026)
Table 27. Global Live Brucellosis Vaccine Market Average Price (US$/Unit) by Region (2027–2032)
Table 28. Global Live Brucellosis Vaccine Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (K Units)
Table 29. Global Live Brucellosis Vaccine Consumption by Region (K Units), 2021–2026
Table 30. Global Live Brucellosis Vaccine Consumption Market Share by Region (2021–2026)
Table 31. Global Live Brucellosis Vaccine Forecasted Consumption by Region (K Units), 2027–2032
Table 32. Global Live Brucellosis Vaccine Forecasted Consumption Market Share by Region (2027–2032)
Table 33. North America Live Brucellosis Vaccine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (K Units)
Table 34. North America Live Brucellosis Vaccine Consumption by Country (K Units), 2021–2026
Table 35. North America Live Brucellosis Vaccine Consumption by Country (K Units), 2027–2032
Table 36. Europe Live Brucellosis Vaccine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (K Units)
Table 37. Europe Live Brucellosis Vaccine Consumption by Country (K Units), 2021–2026
Table 38. Europe Live Brucellosis Vaccine Consumption by Country (K Units), 2027–2032
Table 39. Asia Pacific Live Brucellosis Vaccine Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (K Units)
Table 40. Asia Pacific Live Brucellosis Vaccine Consumption by Region (K Units), 2021–2026
Table 41. Asia Pacific Live Brucellosis Vaccine Consumption by Region (K Units), 2027–2032
Table 42. Latin America, Middle East & Africa Live Brucellosis Vaccine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (K Units)
Table 43. Latin America, Middle East & Africa Live Brucellosis Vaccine Consumption by Country (K Units), 2021–2026
Table 44. Latin America, Middle East & Africa Live Brucellosis Vaccine Consumption by Country (K Units), 2027–2032
Table 45. Global Live Brucellosis Vaccine Production (K Units) by Type (2021–2026)
Table 46. Global Live Brucellosis Vaccine Production (K Units) by Type (2027–2032)
Table 47. Global Live Brucellosis Vaccine Production Market Share by Type (2021–2026)
Table 48. Global Live Brucellosis Vaccine Production Market Share by Type (2027–2032)
Table 49. Global Live Brucellosis Vaccine Production Value (US$ Million) by Type (2021–2026)
Table 50. Global Live Brucellosis Vaccine Production Value (US$ Million) by Type (2027–2032)
Table 51. Global Live Brucellosis Vaccine Production Value Market Share by Type (2021–2026)
Table 52. Global Live Brucellosis Vaccine Production Value Market Share by Type (2027–2032)
Table 53. Global Live Brucellosis Vaccine Price (US$/Unit) by Type (2021–2026)
Table 54. Global Live Brucellosis Vaccine Price (US$/Unit) by Type (2027–2032)
Table 55. Global Live Brucellosis Vaccine Production (K Units) by Application (2021–2026)
Table 56. Global Live Brucellosis Vaccine Production (K Units) by Application (2027–2032)
Table 57. Global Live Brucellosis Vaccine Production Market Share by Application (2021–2026)
Table 58. Global Live Brucellosis Vaccine Production Market Share by Application (2027–2032)
Table 59. Global Live Brucellosis Vaccine Production Value (US$ Million) by Application (2021–2026)
Table 60. Global Live Brucellosis Vaccine Production Value (US$ Million) by Application (2027–2032)
Table 61. Global Live Brucellosis Vaccine Production Value Market Share by Application (2021–2026)
Table 62. Global Live Brucellosis Vaccine Production Value Market Share by Application (2027–2032)
Table 63. Global Live Brucellosis Vaccine Price (US$/Unit) by Application (2021–2026)
Table 64. Global Live Brucellosis Vaccine Price (US$/Unit) by Application (2027–2032)
Table 65. CZ Vaccines Live Brucellosis Vaccine Company Information
Table 66. CZ Vaccines Live Brucellosis Vaccine Specification and Application
Table 67. CZ Vaccines Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 68. CZ Vaccines Main Business and Markets Served
Table 69. CZ Vaccines Recent Developments/Updates
Table 70. MSD Live Brucellosis Vaccine Company Information
Table 71. MSD Live Brucellosis Vaccine Specification and Application
Table 72. MSD Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 73. MSD Main Business and Markets Served
Table 74. MSD Recent Developments/Updates
Table 75. Ceva Live Brucellosis Vaccine Company Information
Table 76. Ceva Live Brucellosis Vaccine Specification and Application
Table 77. Ceva Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 78. Ceva Main Business and Markets Served
Table 79. Ceva Recent Developments/Updates
Table 80. Colorado Serum Live Brucellosis Vaccine Company Information
Table 81. Colorado Serum Live Brucellosis Vaccine Specification and Application
Table 82. Colorado Serum Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 83. Colorado Serum Main Business and Markets Served
Table 84. Colorado Serum Recent Developments/Updates
Table 85. Tecnovax Live Brucellosis Vaccine Company Information
Table 86. Tecnovax Live Brucellosis Vaccine Specification and Application
Table 87. Tecnovax Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 88. Tecnovax Main Business and Markets Served
Table 89. Tecnovax Recent Developments/Updates
Table 90. Syva Live Brucellosis Vaccine Company Information
Table 91. Syva Live Brucellosis Vaccine Specification and Application
Table 92. Syva Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 93. Syva Main Business and Markets Served
Table 94. Syva Recent Developments/Updates
Table 95. Shchelkovo Biocombinat Live Brucellosis Vaccine Company Information
Table 96. Shchelkovo Biocombinat Live Brucellosis Vaccine Specification and Application
Table 97. Shchelkovo Biocombinat Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 98. Shchelkovo Biocombinat Main Business and Markets Served
Table 99. Shchelkovo Biocombinat Recent Developments/Updates
Table 100. Jinyu Baoling Live Brucellosis Vaccine Company Information
Table 101. Jinyu Baoling Live Brucellosis Vaccine Specification and Application
Table 102. Jinyu Baoling Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 103. Jinyu Baoling Main Business and Markets Served
Table 104. Jinyu Baoling Recent Developments/Updates
Table 105. Biovet Live Brucellosis Vaccine Company Information
Table 106. Biovet Live Brucellosis Vaccine Specification and Application
Table 107. Biovet Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 108. Biovet Main Business and Markets Served
Table 109. Biovet Recent Developments/Updates
Table 110. CAVAC Live Brucellosis Vaccine Company Information
Table 111. CAVAC Live Brucellosis Vaccine Specification and Application
Table 112. CAVAC Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 113. CAVAC Main Business and Markets Served
Table 114. CAVAC Recent Developments/Updates
Table 115. VETAL Live Brucellosis Vaccine Company Information
Table 116. VETAL Live Brucellosis Vaccine Specification and Application
Table 117. VETAL Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 118. VETAL Main Business and Markets Served
Table 119. VETAL Recent Developments/Updates
Table 120. Indian Immunologicals Live Brucellosis Vaccine Company Information
Table 121. Indian Immunologicals Live Brucellosis Vaccine Specification and Application
Table 122. Indian Immunologicals Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 123. Indian Immunologicals Main Business and Markets Served
Table 124. Indian Immunologicals Recent Developments/Updates
Table 125. Dollvet Live Brucellosis Vaccine Company Information
Table 126. Dollvet Live Brucellosis Vaccine Specification and Application
Table 127. Dollvet Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 128. Dollvet Main Business and Markets Served
Table 129. Dollvet Recent Developments/Updates
Table 130. Hester Biosciences Live Brucellosis Vaccine Company Information
Table 131. Hester Biosciences Live Brucellosis Vaccine Specification and Application
Table 132. Hester Biosciences Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 133. Hester Biosciences Main Business and Markets Served
Table 134. Hester Biosciences Recent Developments/Updates
Table 135. Qilu Animal Health Live Brucellosis Vaccine Company Information
Table 136. Qilu Animal Health Live Brucellosis Vaccine Specification and Application
Table 137. Qilu Animal Health Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 138. Qilu Animal Health Main Business and Markets Served
Table 139. Qilu Animal Health Recent Developments/Updates
Table 140. Auleon Biologicals Live Brucellosis Vaccine Company Information
Table 141. Auleon Biologicals Live Brucellosis Vaccine Specification and Application
Table 142. Auleon Biologicals Live Brucellosis Vaccine Production (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 143. Auleon Biologicals Main Business and Markets Served
Table 144. Auleon Biologicals Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Live Brucellosis Vaccine Distributors List
Table 148. Live Brucellosis Vaccine Customers List
Table 149. Live Brucellosis Vaccine Market Trends
Table 150. Live Brucellosis Vaccine Market Drivers
Table 151. Live Brucellosis Vaccine Market Challenges
Table 152. Live Brucellosis Vaccine Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Live Brucellosis Vaccine
Figure 2. Global Live Brucellosis Vaccine Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Live Brucellosis Vaccine Market Share by Type: 2025 vs 2032
Figure 4. Strain RB-51 Product Picture
Figure 5. Strain S19 Product Picture
Figure 6. Strain S2 Product Picture
Figure 7. Strain A19 Product Picture
Figure 8. Strain Rev. I Product Picture
Figure 9. Global Live Brucellosis Vaccine Market Value by Application (US$ Million), 2021–2032
Figure 10. Global Live Brucellosis Vaccine Market Share by Application: 2025 vs 2032
Figure 11. Cattle
Figure 12. Sheep
Figure 13. Pig
Figure 14. Others
Figure 15. Global Live Brucellosis Vaccine Production Value (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Live Brucellosis Vaccine Production Value (US$ Million), 2021–2032
Figure 17. Global Live Brucellosis Vaccine Production Capacity (K Units), 2021–2032
Figure 18. Global Live Brucellosis Vaccine Production (K Units), 2021–2032
Figure 19. Global Live Brucellosis Vaccine Average Price (US$/Unit), 2021–2032
Figure 20. Live Brucellosis Vaccine Report Years Considered
Figure 21. Live Brucellosis Vaccine Production Share by Manufacturers in 2025
Figure 22. Global Live Brucellosis Vaccine Production Value Share by Manufacturers (2025)
Figure 23. Live Brucellosis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 24. Top 5 and Top 10 Global Players: Market Share by Live Brucellosis Vaccine Revenue in 2025
Figure 25. Global Live Brucellosis Vaccine Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 26. Global Live Brucellosis Vaccine Production Value Market Share by Region: 2021 vs 2025 vs 2032
Figure 27. Global Live Brucellosis Vaccine Production Comparison by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 28. Global Live Brucellosis Vaccine Production Market Share by Region: 2021 vs 2025 vs 2032
Figure 29. North America Live Brucellosis Vaccine Production Value (US$ Million) Growth Rate (2021–2032)
Figure 30. Europe Live Brucellosis Vaccine Production Value (US$ Million) Growth Rate (2021–2032)
Figure 31. China Live Brucellosis Vaccine Production Value (US$ Million) Growth Rate (2021–2032)
Figure 32. Japan Live Brucellosis Vaccine Production Value (US$ Million) Growth Rate (2021–2032)
Figure 33. Global Live Brucellosis Vaccine Consumption by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 34. Global Live Brucellosis Vaccine Consumption Market Share by Region: 2021 vs 2025 vs 2032
Figure 35. North America Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 36. North America Live Brucellosis Vaccine Consumption Market Share by Country (2021–2032)
Figure 37. U.S. Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 38. Canada Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 39. Europe Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 40. Europe Live Brucellosis Vaccine Consumption Market Share by Country (2021–2032)
Figure 41. Germany Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 42. France Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 43. U.K. Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 44. Italy Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 45. Russia Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 46. Asia Pacific Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 47. Asia Pacific Live Brucellosis Vaccine Consumption Market Share by Region (2021–2032)
Figure 48. China Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 49. Japan Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 50. South Korea Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 51. China Taiwan Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 52. Southeast Asia Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 53. India Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 54. Latin America, Middle East & Africa Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 55. Latin America, Middle East & Africa Live Brucellosis Vaccine Consumption Market Share by Country (2021–2032)
Figure 56. Mexico Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 57. Brazil Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 58. Turkey Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 59. GCC Countries Live Brucellosis Vaccine Consumption and Growth Rate (K Units), 2021–2032
Figure 60. Global Production Market Share of Live Brucellosis Vaccine by Type (2021–2032)
Figure 61. Global Production Value Market Share of Live Brucellosis Vaccine by Type (2021–2032)
Figure 62. Global Live Brucellosis Vaccine Price (US$/Unit) by Type (2021–2032)
Figure 63. Global Production Market Share of Live Brucellosis Vaccine by Application (2021–2032)
Figure 64. Global Production Value Market Share of Live Brucellosis Vaccine by Application (2021–2032)
Figure 65. Global Live Brucellosis Vaccine Price (US$/Unit) by Application (2021–2032)
Figure 66. Live Brucellosis Vaccine Value Chain
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Sales Planning Tool Market Research Report 2026
Feb 03, 26
Global Chromium Oxide Powder Market Research Report 2026
Feb 03, 26
Global Shape Memory Actuator Market Research Report 2026
Feb 03, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232